Cover Image
市場調查報告書

數位治療的全球市場 (2017-2027年):用途 (糖尿病·肥胖·CVD·CNS·呼吸疾病)·終端用戶 (患者·醫療提供者·雇主·保險者·醫藥品企業)·各地區

The Digital Therapeutics Market Forecast 2017-2027: Forecasts by Application (Diabetes, Obesity CVD, CNS, Respiratory) End-User, (Patients, Caregivers, Employers, Payers, Pharmaceutical Companies) and Geography

出版商 Visiongain Ltd 商品編碼 599409
出版日期 內容資訊 英文 234 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
數位治療的全球市場 (2017-2027年):用途 (糖尿病·肥胖·CVD·CNS·呼吸疾病)·終端用戶 (患者·醫療提供者·雇主·保險者·醫藥品企業)·各地區 The Digital Therapeutics Market Forecast 2017-2027: Forecasts by Application (Diabetes, Obesity CVD, CNS, Respiratory) End-User, (Patients, Caregivers, Employers, Payers, Pharmaceutical Companies) and Geography
出版日期: 2017年11月23日 內容資訊: 英文 234 Pages
簡介

2017年全球數位治療的收益規模推算將為130億美元。預計2027年也將記錄強力成長。

本報告提供全球數位治療的市場調查,彙整市場定義和概要,相關技術·法律規章,影響市場成長因素及市場機會分析,用途·終端用戶·地區/主要國家趨勢與市場規模的變化與預測,主要企業簡介等資訊。

第1章 報告概要

  • 市場動態
  • 成長推進因素
  • 阻礙成長要素
  • 市場趨勢
    • 技術
    • 法律規章
    • 醫療費的擴大
  • 市場機會
    • 遠端保健
    • 分析
  • 波特的五力分析

第3章 市場分析·預測:各用途

  • 簡介
  • 市場規模·預測
    • 糖尿病
    • 肥胖
    • CVD
    • CNS
    • 呼吸系統
    • 其他
  • 市場魅力

第4章 市場分析·預測:各終端用戶

  • 簡介
  • 市場規模·預測
    • 患者
    • 醫療提供者
    • 雇主
    • 保險者
    • 醫藥品企業
  • 市場魅力
  • 市場分析·預測:各地區

第5章 北美市場分析·預測

  • 簡介
  • 市場預測:各國
    • 美國
    • 加拿大
  • 市場預測:各用途
  • 市場預測:終端用戶
  • 市場魅力

第6章 南美市場分析·預測

  • 簡介
  • 市場預測:各國
    • 墨西哥
    • 其他
  • 市場預測:各用途
  • 市場預測:終端用戶
  • 市場魅力

第7章 歐洲市場分析·預測

  • 簡介
  • 市場預測:各國
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 市場預測:各用途
  • 市場預測:終端用戶
  • 市場魅力

第8章 亞太地區市場分析·預測

  • 簡介
  • 市場預測:各國
    • 中國
    • 印度
    • 澳洲&紐西蘭
    • 日本
    • 東南亞國協
    • 韓國
    • 其他
  • 市場預測:各用途
  • 市場預測:終端用戶
  • 市場魅力

第9章 中東市場分析·預測

  • 簡介
  • 市場預測:各國
    • GCC各國
    • 以色列
  • 市場預測:各用途
  • 市場預測:終端用戶
  • 市場魅力

第10章 非洲市場分析·預測

  • 簡介
  • 市場預測:各國
    • 南非
    • 中非
    • 北非
  • 市場預測:各用途
  • 市場預測:終端用戶
  • 市場魅力

第11章 企業簡介

  • Omada Health
  • Canary Health
  • Noom Inc.
  • Livongo Health
  • WellDoc Inc.
  • Propeller Health
  • Evolent Health
  • Doximity
  • Perfint Healthcare
  • Proteus Digital Health Inc.
  • 其他

第12章 總論

第13章 用語

目錄
Product Code: ELE0002

Digital Therapeutics - our new study reveals trends, R&D progress, and predicted revenues Where is the Digital Therapeutics market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead

Our 234-page report provides 206 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Digital Therapeutics market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

image1

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are forecasts for 6 Digital Therapeutics Applications and 5 End Users in the report at a global and regional level:

Global Digital Therapeutics Market by Application

  • Obesity
  • Diabetes
  • CNS
  • CVD
  • Respiratory
  • Other

Global Digital Therapeutics Market by End User

  • Patients
  • Payers
  • Caregivers
  • Employers
  • Pharmaceutical Companies

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 6 major regional and 21 major national markets:

  • North America:
  • The US
  • Canada
  • Latin America:
  • Brazil
  • Mexico
  • Rest of Latin America
  • Europe:
  • Germany
  • The UK
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia-Pacific:
  • China
  • India
  • Japan
  • ASEAN
  • Australia and New Zealand
  • South Korea
  • Rest of Asia-Pacific
  • Middle East:
  • GCC Countries
  • Israel
  • Africa:
  • South Africa
  • Central Africa
  • North Africa

The report also includes profiles and for some of the leading companies in the Digital Therapeutics market, with a focus on this segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, the US, the UK and the APAC region in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth

Overall world revenue for Digital Therapeutics will surpass $1.3bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Digital Therapeutics Market report helps you

In summary, our 234-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for the Digital Therapeutics market, with forecasts for 6 applications and 5 end-users across 6 key regional markets as well as forecasts for 21 major national markets - See forecasts for the Digital Therapeutics market in North America, Latin America, Europe, Asia-Pacific, the Middle East and Africa, as well as the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Russia, Japan, China, India, Australia and New Zealand, ASEAN countries, South Korea, GCC Countries, Israel and South Africa, Central Africa and North Africa
  • What stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market - including company profiles for some of the major companies involved in the Digital Therapeutics market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Digital Therapeutics market and leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1. Global Digital Therapeutics Market Overview
  • 1.2. Why You Should Read This Report
  • 1.3. How This Report Delivers
  • 1.4. Key Questions Answered by This Analytical Report Include:
  • 1.5. Who is This Report For?
  • 1.6. Methodology
    • 1.6.1. Primary Research
    • 1.6.2. Secondary Research
    • 1.6.3. Market Evaluation &Forecasting Methodology
  • 1.7. Frequently Asked Questions (FAQ)
  • 1.8. Associated Visiongain Reports
  • 1.9. About Visiongain
  • 1.10. Introduction to the Digital Therapeutics Market
  • 1.11. Digital Therapeutics Market Structure
  • 1.12. Digital Therapeutics Market Definition
  • 1.13. Digital Therapeutics Market Application Category Submarkets Definition
    • 1.13.1. Digital Therapeutics Diabetes Submarket Definition
    • 1.13.2. Digital Therapeutics Obesity Submarket Definition
    • 1.13.3. Digital Therapeutics Market Cardiovascular Disease Submarket Definition
  • 1.14. Digital Therapeutics Market Taxonomy

2. Global Digital Therapeutics Market Snapshot

  • 2.1. Global Digital Therapeutics Market Dynamics
  • 2.2. Global Digital Therapeutics Market: Drivers
    • 2.2.1. Demographic Shift
    • 2.2.2. Rising Incidence of Chronic Disorders
    • 2.2.3. Technological Advancements
    • 2.2.4. Increased Venture Funding for Start-up
    • 2.2.5. Rising Healthcare Cost
    • 2.2.6. Rise in Smartphone Consumption
    • 2.2.7. Government Initiatives
    • 2.2.8. Patient Awareness for Better Products
  • 2.3. Global Digital Therapeutics Market: Restraints
    • 2.3.1. High Cost and Less Adoption in Emerging Countries
  • 2.4. Global Digital Therapeutics Market: Trends
    • 2.4.1. Technology
    • 2.4.2. Government Regulations
    • 2.4.3. Rise in Medical Spending
  • 2.5. Global Digital Therapeutics Market: Opportunities
    • 2.5.1. Tele-health
    • 2.5.2. Analytics
  • 2.6. Global Digital Therapeutics Market: Porter's Five Forces Model
    • 2.6.1. Substitute Services and Products
    • 2.6.2. Buyer Power
    • 2.6.3. Power of Supplier
    • 2.6.4. Existing Rivalry
    • 2.6.5. New Entrants

3. Global Digital Therapeutics Market, By Application, 2017-2027

  • 3.1. Introduction
  • 3.2. Global Digital Therapeutics Market Size and Forecast, By Application
    • 3.2.1. Diabetes Segment
    • 3.2.2. Obesity Segment
    • 3.2.3. CVD Segment
    • 3.2.4. CNS Segment
    • 3.2.5. Respiratory Segment
    • 3.2.6. Others Segment
  • 3.3. Global Digital Therapeutics Market Attractiveness Index, By Application

4. Global Digital Therapeutics Market, By End-User, 2017-2027

  • 4.1. Introduction
  • 4.2. Global Digital Therapeutics Market Size and Forecast, By End-User
    • 4.2.1. Patients Segment
    • 4.2.2. Caregivers Segment
    • 4.2.3. Employers Segment
    • 4.2.4. Payers Segment
    • 4.2.5. Pharmaceutical Companies Segment
  • 4.3. Global Digital Therapeutics Market Attractiveness Index, By End-User
  • 4.4. Introduction
  • 4.5. Global Digital Therapeutics Market Size and Forecast, By Region
    • 4.5.1. North America
    • 4.5.2. Latin America
    • 4.5.3. Europe
    • 4.5.4. Asia Pacific
    • 4.5.5. Middle East
    • 4.5.6. Africa
  • 4.6. Global Digital Therapeutics Market Attractiveness Index, By Region
  • 4.7. Leading Digital Therapeutics Market, Forecast 2017-2027, By Region

5. North America Digital Therapeutics Market Analysis and Forecast, 2017-2027

  • 5.1. Introduction
    • 5.1.1. North America
  • 5.2. North America Digital Therapeutics Market Forecast, By Country, 2017-2027
    • 5.2.1. U.S.
    • 5.2.2. Canada
  • 5.3. North America Medical Equipment Market, By Application
  • 5.4. North America Medical Equipment Market, By End-User
  • 5.5. North America Digital Therapeutics Market Attractiveness Index
    • 5.5.1. By Application
    • 5.5.2. By End-User
    • 5.5.3. By Country

6. Latin America Digital Therapeutics Market Analysis and Forecast, 2017-2027

  • 6.1. Introduction
    • 6.1.1. Latin America
  • 6.2. Latin America Digital Therapeutics Market Forecast, By Country, 2017-2027
    • 6.2.1. Brazil
    • 6.2.2. Mexico
    • 6.2.3. Rest of Latin America
  • 6.3. Latin America Medical Equipment Market, By Application
  • 6.4. Latin America Medical Equipment Market, By End-User
  • 6.5. Latin America Digital Therapeutics Market Attractiveness Index
    • 6.5.1. By Application
    • 6.5.2. By End-User
    • 6.5.3. By Country

7. Europe Digital Therapeutics Market Analysis and Forecast, 2017-2027

  • 7.1. Introduction
  • 7.2. Europe Digital Therapeutics Market Forecast, By Country, 2017-2027
    • 7.2.1. U.K.
    • 7.2.2. France
    • 7.2.3. Germany
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Russia
    • 7.2.7. Rest of Europe
  • 7.3. Europe Medical Equipment Market, By Application
  • 7.4. Europe Medical Equipment Market, By End-User
  • 7.5. Europe Digital Therapeutics Market Attractiveness Index
    • 7.5.1. By Application
    • 7.5.2. By End-User
    • 7.5.3. By Country

8. Asia Pacific Digital Therapeutics Market Analysis and Forecast, 2017-2027

  • 8.1. Introduction
  • 8.2. Asia Pacific Digital Therapeutics Market Forecast, By Country, 2017-2027
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Australia and New Zealand
    • 8.2.4. Japan
    • 8.2.5. ASEAN
    • 8.2.6. South Korea
    • 8.2.7. Rest of Asia Pacific
  • 8.3. Asia Pacific Medical Equipment Market, By Application
  • 8.4. Asia Pacific Medical Equipment Market, By End-User
  • 8.5. Asia Pacific Digital Therapeutics Market Attractiveness Index
    • 8.5.1. By Application
    • 8.5.2. By End-User
    • 8.5.3. By Country

9. Middle East Therapeutics Market Analysis and Forecast, 2017-2027

  • 9.1. Introduction
  • 9.2. Middle East Digital Therapeutics Market Forecast, By Country, 2017-2027
    • 9.2.1. GCC Countries
    • 9.2.2. Israel
  • 9.3. Middle East Medical Equipment Market, By Application
  • 9.4. Middle East Medical Equipment Market, By End-User
  • 9.5. Middle East Digital Therapeutics Market Attractiveness Index
    • 9.5.1. By Application
    • 9.5.2. By End-User
    • 9.5.3. By Country

10. Africa Therapeutics Market Analysis and Forecast, 2017-2027

  • 10.1. Introduction
  • 10.2. Africa Digital Therapeutics Market Forecast, By Country, 2017-2027
    • 10.2.1. South Africa
    • 10.2.2. Central Africa
    • 10.2.3. North Africa
  • 10.3. Africa Medical Equipment Market, By Application
  • 10.4. Africa Medical Equipment Market, By End-User
  • 10.5. Africa Digital Therapeutics Market Attractiveness Index
    • 10.5.1. By Application
    • 10.5.2. By End-User
    • 10.5.3. By Country

11. Company Profiles

  • 11.1. Omada Health
    • 11.1.1. Company Overview
    • 11.1.2. Key Developments
  • 11.2. Canary Health
    • 11.2.1. Company Overview
    • 11.2.2. Key Developments
  • 11.3. Noom Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Key Developments
  • 11.4. Livongo Health
    • 11.4.1. Company Overview
    • 11.4.2. Key Developments
  • 11.5. WellDoc Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Key Developments
  • 11.6. Propeller Health
    • 11.6.1. Company Overview
    • 11.6.2. Key Developments
  • 11.7. Evolent Health
    • 11.7.1. Company Overview
  • 11.8. Doximity
    • 11.8.1. Doximity Company Overview
    • 11.8.2. Key Developments
  • 11.9. Perfint Healthcare
    • 11.9.1. Company Overview
  • 11.10. Proteus Digital Health Inc.
    • 11.10.1. Company Overview
  • 11.11. Other Companies of Interest in the Digital Therapeutics Market

12. Conclusion

13. Glossary

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 1.1 Global Digital Therapeutics Market Segmentation Overview
  • Figure 1.2 Global Digital Therapeutics Market Forecast
  • Figure 2.1: Global Digital Therapeutics Market Forecast Value (US$ Bn) Forecast and AGR%, 2016-2027
  • Figure 2.2 Global Digital Therapeutics Market Porter's Five Forces Model
  • Figure 3.1 Global Digital Therapeutics Market, By Application, AGR Forecast 2017-2027 (AGR %)
  • Figure 3.2 Global Digital Therapeutics Market, By Application Segment Forecast 2017-2027 (US$Bn, Global AGR %)
  • Figure 3.3: Global Digital Therapeutics Market, Market Share Split & BPS Analysis, By Application, 2017-2027
  • Figure 3.4 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Diabetes Segment, 2016-2027
  • Figure 3.5 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Obesity, 2016-2027
  • Figure 3.6 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By CVD, 2016-2027
  • Figure 3.7 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By CNS, 2016-2027
  • Figure 3.8 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Respiratory, 2016-2027
  • Figure 3.9 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Others, 2016-2027
  • Figure 3.10 Global Digital Therapeutics Market Attractiveness Index, By Application, 2017-2027
  • Figure 4.1 Global Digital Therapeutics Market, By End-User, AGR Forecast 2017-2027 (AGR %)
  • Figure 4.2 Global Digital Therapeutics Market, By End-User Segment Forecast 2017-2027 (US$Bn, Global AGR %)
  • Figure 4.3: Global Digital Therapeutics Market, Market Share Split & BPS Analysis, By End-User Segment, 2017-2027
  • Figure 4.4 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Patients Segment, 2016-2027
  • Figure 4.5 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Caregivers Segment, 2016-2027
  • Figure 4.6 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Employers Segment, 2016-2027
  • Figure 4.7 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Payers Segment, 2016-2027
  • Figure 4.8 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Pharmaceutical Segment, 2016-2027
  • Figure 4.9 Global Digital Therapeutics Market Attractiveness Index, By End-User, 2017-2027
  • Figure 4.10 Global Digital Therapeutics Market, By Region, AGR Forecast 2017-2027 (AGR %)
  • Figure 4.11 Global Digital Therapeutics Market, By Region Segment Forecast 2017-2027 (US$Bn, Global AGR %)
  • Figure 4.12 Global Digital Therapeutics Market, Market Share Split & BPS Analysis, By Region Segment, 2017-2027
  • Figure 4.13 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By North America, 2016-2027
  • Figure 4.14 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Latin America, 2016-2027
  • Figure 4.15 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Europe, 2016-2027
  • Figure 4.16 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Asia Pacific, 2016-2027
  • Figure 4.17 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Middle East, 2016-2027
  • Figure 4.18 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Africa, 2016-2027
  • Figure 4.19 Global Digital Therapeutics Market Attractiveness Index, By Region, 2017-2027
  • Figure 4.20 Global Digital Therapeutics Market by Region Submarket Share Forecast 2017 (% Share)
  • Figure 4.21 Global Digital Therapeutics Market by Region Submarket Share Forecast 2022 (% Share)
  • Figure 4.22 Global Digital Therapeutics Market by Region Segment Submarket Share Forecast 2027 (% Share)
  • Figure 4.23 Global Digital Therapeutics Market Share by Countries Market Forecast 2017 (% Share)
  • Figure 4.24 Global Digital Therapeutics Market Share by Countries Market Forecast 2022 (% Share)
  • Figure 4.25 Global Digital Therapeutics Market Share by Countries Market Forecast 2027 (% Share)
  • Figure 5.1 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By North America, 2016-2027
  • Figure 5.2 North America Digital Therapeutics Market, By Country, AGR Forecast 2017-2027 (AGR %)
  • Figure 5.3 North America Digital Therapeutics Market, By Country Segment Forecast 2017-2027 (US$Bn, Global AGR %)
  • Figure 5.4 North America Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017-2027
  • Figure 5.5 North America Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By the U.S., 2016-2027
  • Figure 5.6 North America Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Canada, 2016-2027
  • Figure 5.7 North America Digital Therapeutics Market by Country Submarket Share Forecast 2017 (% Share)
  • Figure 5.8 North America Digital Therapeutics Market by Country Submarket Share Forecast 2022 (% Share)
  • Figure 5.9 North America Digital Therapeutics Market by Country Submarket Share Forecast 2027 (% Share)
  • Figure 5.10 North America Digital Therapeutics Market Attractiveness Index, By Application, 2017-2027
  • Figure 5.11 North America Digital Therapeutics Market Attractiveness Index, By End-User, 2017-2027
  • Figure 5.12 North America Digital Therapeutics Market Attractiveness Index, By Country, 2017-2027
  • Figure 6.1 Latin America Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%),2016-2027
  • Figure 6.2 Latin America Digital Therapeutics Market, By Country, AGR Forecast 2017-2027 (AGR %)
  • Figure 6.3 Latin America Digital Therapeutics Market, By Country Segment Forecast 2017-2027 (US$Bn, Latin America AGR %)
  • Figure 6.4 Latin America Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017-2027
  • Figure 6.5 Latin America Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Brazil, 2016-2027
  • Figure 6.6 Latin America Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Mexico, 2016-2027
  • Figure 6.7 Latin America Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Rest of Latin America, 2016-2027
  • Figure 6.8 Latin America Digital Therapeutics Market by Country Submarket Share Forecast 2017 (% Share)
  • Figure 6.9 Latin America Digital Therapeutics Market by Country Submarket Share Forecast 2022 (% Share)
  • Figure 6.10 Latin America Digital Therapeutics Market by Country Submarket Share Forecast 2027 (% Share)
  • Figure 6.11 Latin America Digital Therapeutics Market Attractiveness Index, By Application, 2017-2027
  • Figure 6.12 Latin America Digital Therapeutics Market Attractiveness Index, By End-User, 2017-2027
  • Figure 6.13 Latin America Digital Therapeutics Market Attractiveness Index, By Country, 2017-2027
  • Figure 7.1 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%),2016-2027
  • Figure 7.2 Europe Digital Therapeutics Market, By Country, AGR Forecast 2017-2027 (AGR %)
  • Figure 7.3 Europe Digital Therapeutics Market, By Country Segment Forecast 2017-2027 (US$Bn, Europe AGR %)
  • Figure 7.4 Europe Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017-2027
  • Figure 7.5 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By U.K., 2016-2027
  • Figure 7.6 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By France, 2016-2027
  • Figure 7.7 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Germany, 2016-2027
  • Figure 7.8 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Italy, 2016-2027
  • Figure 7.9 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Spain, 2016-2027
  • Figure 7.10 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Russia, 2016-2027
  • Figure 7.11 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Rest of Europe, 2016-2027
  • Figure 7.12 Europe Digital Therapeutics Market by Country Submarket Share Forecast 2017 (% Share)
  • Figure 7.13 Europe Digital Therapeutics Market by Country Submarket Share Forecast 2022 (% Share)
  • Figure 7.14 Europe Digital Therapeutics Market by Country Submarket Share Forecast 2027 (% Share)
  • Figure 7.15 Europe Digital Therapeutics Market Attractiveness Index, By Application, 2017-2027
  • Figure 7.16 Europe Digital Therapeutics Market Attractiveness Index, By End-User, 2017-2027
  • Figure 7.17 Europe Digital Therapeutics Market Attractiveness Index, By Country, 2017-2027
  • Figure 8.1 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%),2016-2027
  • Figure 8.2 Asia Pacific Digital Therapeutics Market, By Country, AGR Forecast 2017-2027 (AGR %)
  • Figure 8.3 Asia Pacific Digital Therapeutics Market, By Country Segment Forecast 2017-2027 (US$Bn, Asia Pacific AGR %)
  • Figure 8.4 Asia Pacific Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017-2027
  • Figure 8.5 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By China, 2016-2027
  • Figure 8.6 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By India, 2016-2027
  • Figure 8.7 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Australia and New Zealand, 2016-2027
  • Figure 8.8 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Japan, 2016-2027
  • Figure 8.9 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By ASEAN, 2016-2027
  • Figure 8.10 South Korea Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By South Korea, 2016-2027
  • Figure 8.11 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Rest of Asia Pacific, 2016-2027
  • Figure 8.12 Asia Pacific Digital Therapeutics Market by Country Submarket Share Forecast 2017 (% Share)
  • Figure 8.13 Asia Pacific Digital Therapeutics Market by Country Submarket Share Forecast 2022 (% Share)
  • Figure 8.14 Asia Pacific Digital Therapeutics Market by Country Submarket Share Forecast 2027 (% Share)
  • Figure 8.15 Asia Pacific Digital Therapeutics Market Attractiveness Index, By Application, 2017-2027
  • Figure 8.16 Asia Pacific Digital Therapeutics Market Attractiveness Index, By End-User, 2017-2027
  • Figure 8.17 Asia Pacific Digital Therapeutics Market Attractiveness Index, By Country, 2017-2027
  • Figure 9.1 Middle East Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%),2016-2027
  • Figure 9.2 Middle East Digital Therapeutics Market, By Country, AGR Forecast 2017-2027 (AGR %)
  • Figure 9.3 Middle East Digital Therapeutics Market, By Country Segment Forecast 2017-2027 (US$Bn, AGR %)
  • Figure 9.4 Middle East Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017-2027
  • Figure 9.4 Middle East Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017-2027
  • Figure 9.5 Middle East Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By GCC, 2016-2027
  • Figure 9.6 Middle East Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Israel, 2016-2027
  • Figure 9.7 Middle East Digital Therapeutics Market by Country Submarket Share Forecast 2017 (% Share)
  • Figure 9.8 Middle East Digital Therapeutics Market by Country Submarket Share Forecast 2022 (% Share)
  • Figure 9.9 Middle East Digital Therapeutics Market by Country Submarket Share Forecast 2027 (% Share)
  • Figure 9.10 Middle East Digital Therapeutics Market Attractiveness Index, By Application, 2017-2027
  • Figure 9.11 Middle East Digital Therapeutics Market Attractiveness Index, By End-User, 2017-2027
  • Figure 9.12 Middle East Digital Therapeutics Market Attractiveness Index, By Country, 2017-2027
  • Figure 10.1 Middle East Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), 2016-2027
  • Figure 10.2 Middle East Digital Therapeutics Market, By Country, AGR Forecast 2017-2027 (AGR %)
  • Figure 10.3 Africa Digital Therapeutics Market, By Country Segment Forecast 2017-2027 (US$Bn, AGR %)
  • Figure 10.4 Middle East Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017-2027
  • Figure 10.5 Africa Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By South Africa, 2016-2027
  • Figure 10.6 Africa Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By South Africa, 2016-2027
  • Figure 10.7 Africa Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By North Africa, 2016-2027
  • Figure 10.8 Africa Digital Therapeutics Market by Country Submarket Share Forecast 2017 (% Share)
  • Figure 10.9 Africa Digital Therapeutics Market by Country Submarket Share Forecast 2022 (% Share)
  • Figure 10.10 Middle East Digital Therapeutics Market by Country Submarket Share Forecast 2027 (% Share)
  • Figure 10.11 Africa Digital Therapeutics Market Attractiveness Index, By Application, 2017-2027
  • Figure 10.12 Africa Digital Therapeutics Market Attractiveness Index, By End-User, 2017-2027
  • Figure 10.13 Africa Digital Therapeutics Market Attractiveness Index, By Country, 2017-2027

List of Tables

  • Table 1.1 Digital Therapeutics Market by Regional Market Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 2.1 Global Digital Therapeutics Market Forecast 2017-2027 (US$m, AGR %, CAGR %, Cumulative)
  • Table 3.1 Global Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 3.2 Global Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
  • Table 3.3 Global Digital Therapeutics Market, By Application Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 4.1 Global Digital Therapeutics Market, By End-User Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 4.2 Global Digital Therapeutics Market Forecast, By End-User Segment ($Bn, AGR%) 2016-2027
  • Table 4.3 Global Digital Therapeutics Market, By End-User Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 4.4 Global Digital Therapeutics Market, By Region Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 4.5 Global Digital Therapeutics Market Forecast, By Region Segment ($Bn, AGR%) 2016-2027
  • Table 4.6 Global Digital Therapeutics Market, By Region CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 4.7 Leading Digital Therapeutics Market by Region Forecast 2017-2027 (US$Bn, Global AGR %, Cumulative)
  • Table 4.7 Leading Digital Therapeutics Market by Region Forecast 2017-2027 (US$Bn, Global AGR %, Cumulative)
  • Table 5.1 North Digital Therapeutics Market Forecast, ($Bn, AGR%) 2016-2027
  • Table 5.2 North America Digital Therapeutics Market, By Country Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 5.3 North America Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 5.4 North America Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
  • Table 5.5 North America Digital Therapeutics Market, By Application Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 5.6 North America Digital Therapeutics Market, By End-User Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 5.7 North America Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
  • Table 5.8 North America Digital Therapeutics Market, By End-User, CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 6.1 Latin America Digital Therapeutics Market Forecast, ($Bn, AGR%) 2016-2027
  • Table 6.2 Latin America Digital Therapeutics Market, By Country Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 6.3 Latin America Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 6.4 Latin America Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
  • Table 6.5 Latin America Digital Therapeutics Market, By End-User Forecast 2016-2027 (US$Bn, AGR %, Cumulative)
  • Table 6.6 Latin America Digital Therapeutics Market Forecast, By End-User, Sub-Segment ($Bn, AGR%) 2016-2027
  • Table 6.7 Latin America Digital Therapeutics Market, By End-User Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 7.1 Europe Digital Therapeutics Market Forecast, ($Bn, AGR%) 2016-2027
  • Table 7.2 Europe Digital Therapeutics Market, By Country Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 7.3 Europe Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 7.4 Europe Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
  • Table 7.5 Europe Digital Therapeutics Market, By Application Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 7.6 Europe Digital Therapeutics Market, By End-User Forecast 2016-2027 (US$Bn, AGR %, Cumulative)
  • Table 7.7 Europe Digital Therapeutics Market, By End-User Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 8.1 Asia Pacific Digital Therapeutics Market Forecast, ($Bn, AGR%) 2016-2027
  • Table 8.2 Asia Pacific Digital Therapeutics Market, By Country Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 8.3 Asia Pacific Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 8.4 Asia Pacific Digital Therapeutics Market, By Application Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 8.5 Asia Pacific Digital Therapeutics Market, By End-User Forecast 2016-2027 (US$Bn, AGR %, Cumulative)
  • Table 8.6 Asia Pacific Digital Therapeutics Market Forecast, By End-User, Sub-Segment ($Bn, AGR%) 2016-2027
  • Table 8.7 Asia Pacific Digital Therapeutics Market by Patients End-User Sub-Segment Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 8.8 Asia Pacific Digital Therapeutics Market, By Caregivers End-User Sub-Segment Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 8.9 Asia Pacific Digital Therapeutics Market by End-User, Patients Sub-segment, 2016-2027
  • Table 8.10 Asia Pacific Digital Therapeutics Market, By End-User, Sub-Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 9.1 Middle East Digital Therapeutics Market Forecast, ($Bn, AGR%) 2016-2027
  • Table 9.2 Middle East Digital Therapeutics Market, By Country Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 9.3 Middle East Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 9.4 Middle East Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
  • Table 9.5 Middle East Digital Therapeutics Market, By Application Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 9.6 Middle East Digital Therapeutics Market, By End-User Forecast 2016-2027 (US$Bn, AGR %, Cumulative)
  • Table 9.7 Middle East Digital Therapeutics Market Forecast, By End-User, Sub-Segment ($Bn, AGR%) 2016-2027
  • Table 9.8 Middle East Digital Therapeutics Market, By End-User Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 10.1 Middle East Digital Therapeutics Market Forecast, ($Bn, AGR%) 2016-2027
  • Table 10.2 Africa Digital Therapeutics Market, By Country Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 10.3 Africa Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
  • Table 10.4 Africa Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
  • Table 10.5 Africa Digital Therapeutics Market, By Application Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 10.6 Africa Digital Therapeutics Market, By End-User Forecast 2016-2027 (US$Bn, AGR %, Cumulative)
  • Table 10.7 Africa Digital Therapeutics Market Forecast, By End-User Segment ($Bn, AGR%) 2016-2027
  • Table 10.8 Africa Digital Therapeutics Market, By End-User Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
  • Table 11.1 Omada Health Profile 2016
  • Table 11.2 Omada Health Key Developments
  • Table 11.3 Canary Health Profile 2016
  • Table 11.4 Canary Health Key Developments
  • Table 11.5 Noom Inc. Profile 2016
  • Table 11.6 Noom Inc. Key Developments
  • Table 11.7 Livongo Health Profile 2016
  • Table 11.8 Livongo Health
  • Table 11.9 WellDoc Inc. Profile 2016
  • Table 11.10 WellDoc Inc. Key Developments
  • Table 11.11 Propeller Health Profile 2016
  • Table 11.12 Propeller Health Key Developments
  • Table 11.13 Evolent Health Profile 2016
  • Table 11.14 Evolent Health Total Company Sales 2015-2016 (US$mn AGR%)
  • Table 11.15 Evolent Health Financial Statement 2015-2016
  • Table 11.16 Doximity Profile 2016
  • Table 11.17 Doximity Key Developments
  • Table 11.18 Perfint Healthcare Profile 2016
  • Table 11.19 Proteus Digital Health Inc. Profile 2016
  • Table 11.20 Other Companies of Interest in the Digital Therapeutics Market
  • Table 11.20 Other Companies of Interest in the Digital Therapeutics Market

Companies Listed

  • 2Breathe Technologies Ltd
  • 2Morrow, Inc
  • AdhereTech
  • Adherium
  • AEGLE Palette
  • Affine Healthcare
  • Arthro Therapeutics
  • Arthro Therapeutics
  • Augmedix
  • Beneufit
  • betweenMD, LLC
  • Big White Wall
  • BiogeniQ
  • BioTrak Health
  • BioTrak Therapeutics
  • Blue Mesa Health
  • Butterfly Network
  • Canary Health
  • Chrono Therapeutics
  • Claritas MindSciences
  • CliniOps
  • Doximity
  • Dthera Sciences
  • Evolent Health
  • Firstbeat
  • Ginger.io
  • Glooko
  • Healark
  • Jintronix
  • kaia health
  • Limbix
  • MEDIMETRICS
  • MEDIMETRICS
  • MedRhythms Inc.
  • Meru Health
  • Nanobiosym
  • NeuroTrack Technologies, Inc.
  • Noom, Inc.,
  • Omada Health
  • Oscar
  • Oviva AG
  • Pathology Diagnostics Ltd.
  • Pear Therapeutics
  • Perfint Healthcare
  • Propeller Health
  • Proteus Digital Health
  • RespondWell
  • Ria Health
  • SilverCloud Health
  • Sonormed
  • SpellBound
  • Twine Health
  • Wearable Therapeutics Inc.
  • WellDoc, Inc
  • Yagram Health
  • ZappRx
  • Zest Health

Organisations Mentioned in this Report

  • European Medicines Agency
  • Food and Drug Administration (U S)
  • Ministry of Health, Labor and Welfare
  • National Health Service (UK)
Back to Top